bitBiome develops a data-driven platform for bio-manufacturing centered on its single-cell microbial genome sequencing technology (bit-MAP®) and a proprietary microbial gene database (bit-GEM) that has grown from 2 billion to over 3 billion genes. The company pairs bioinformatics, machine learning/AI, and high-throughput screening including robotics to enable enzyme discovery, enzyme and metabolic-pathway design, and microbial strain engineering via platforms such as bit-QED and bit-EVO. It has expanded leadership with experienced global hires and forged commercial partnerships and CMO ties to support end-to-end research-to-manufacturing workflows, including collaborations with Tojo Vikas International, Kyoritsu Seiyaku, and Sanwa Starch. bitBiome has been selected for large public projects (e.g., NEDO) and published research using bit-MAP® with multiple research groups, and has begun U.S. sampling to expand its database. The company plans to use recent funding to further grow bit-GEM, advance its SENS-AI genome-biology model, expand labs for data collection, and scale global business development, and has reported cumulative funding of about ¥7.0 billion.

Total raised

$37M

Funding rounds

7

Latest round

Seed

Latest activity

May 2026